Global Electrophysiology Devices Market Report and Forecast 2023-2031
Global Electrophysiology Devices Market Outlook
The global electrophysiology devices market value was USD 6.17 billion in 2022, driven by the increasing prevalence of cardiac arrhythmias across the globe. The market size is anticipated to grow at a CAGR of 10% during the forecast period of 2023-2031 to achieve a value of USD 14.5 billion by 2031.
Electrophysiology Introduction
Electrophysiology is a branch of cardiology that deals with the study, diagnosis, and treatment of cardiac electrical activity and abnormal heart rhythms, also known as arrhythmias. The electrophysiology devices market primarily comprises diagnostic and therapeutic devices used in electrophysiological procedures. Diagnostic devices include electrophysiology (EP) recording systems, EP mapping systems, and intracardiac echocardiography systems. Therapeutic devices consist of cardiac ablation catheters, pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.
Electrophysiology Devices Market Scenario
The global electrophysiology devices market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of cardiac arrhythmias, advancements in electrophysiology technologies, and the growing demand for minimally invasive procedures.
North America: The largest market for electrophysiology, driven by factors such as the advanced healthcare infrastructure, a high prevalence of cardiac arrhythmias, and the presence of major electrophysiology device manufacturers.
Europe: The second-largest market, with increasing demand for electrophysiology devices due to a growing aging population and a supportive regulatory framework.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Electrophysiology Devices Market Segmentations
Market Breakup by Type
- Treatment Devices
- Implantable Cardioverter Defibrillators (ICDs)
- Automated external defibrillators (AEDs)
- Pacemakers
- CRT-P
- CRT-D
- Catheters
- Others
- Diagnostic Devices
- Holter Monitoring Devices
- Diagnostic Electrophysiology Catheters
- Electrocardiograph (ECG)
- EP Mapping & Imaging Systems
- Insertable cardiac monitors (ICM)
- Others
- Atrial Fibrillation (AF)
- Supraventricular Tachycardia (SVT)
- Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WPW)
- Bradycardia
- Others
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Electrophysiology Devices Market
Some key trends of the market are as follows:
- Advancements in electrophysiology technologies: The development of new technologies, such as 3D mapping systems, high-resolution imaging, and remote navigation systems, has improved the accuracy, safety, and efficiency of electrophysiological procedures, contributing to market expansion.
- Growing demand for minimally invasive procedures: The increasing preference for minimally invasive electrophysiological procedures, such as catheter ablation, has driven market growth and innovation.
- Increasing prevalence of cardiac arrhythmias: The rising prevalence of cardiac arrhythmias, particularly atrial fibrillation, among the aging global population has led to greater demand for advanced diagnostic and therapeutic electrophysiology solutions.
Electrophysiology Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Johnson & Johnson Private Limited
- BIOTRONIK SE & Co KG
- Abbott
- Medtronic
- Boston Scientific Corporation
- B. Braun Melsungen AG
- BD
- Baxter
- Koninklijke Philips N.V.
- General Electric
- Medline Industries, Inc.
- Danaher
- Siemens Healthcare GmbH
- MicroPort Scientific Corporation
- LivaNova PLC
- Cardiofocus
- Mogul Enterprises, Inc.
- AtriCure, Inc.
- Japan Lifeline Co., Ltd.
- ARGON MEDICAL
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Electrophysiology Devices Market Overview
- 3.1 Global Electrophysiology Devices Market Historical Value (2016-2022)
- 3.2 Global Electrophysiology Devices Market Forecast Value (2023-2031)
- 4 Global Electrophysiology Devices Market Landscape
- 4.1 Global Electrophysiology Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Electrophysiology Devices Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Indication
- 4.2.3 Analysis by End User
- 5 Global Electrophysiology Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Electrophysiology Devices Market Segmentation
- 6.1 Global Electrophysiology Devices Market, by Type
- 6.1.1 Market Overview
- 6.1.2 Treatment Devices
- 6.1.2.1 Implantable Cardioverter Defibrillators (ICDs)
- 6.1.2.2 Automated external defibrillators (AEDs)
- 6.1.2.3 Pacemakers
- 6.1.2.3.1 CRT-P
- 6.1.2.3.2 CRT-D
- 6.1.2.3.3 Catheters
- 6.1.2.3.4 Others
- 6.1.3 Diagnostic Devices
- 6.1.3.1 Holter Monitoring Devices
- 6.1.3.2 Diagnostic Electrophysiology Catheters
- 6.1.3.3 Electrocardiograph (ECG)
- 6.1.3.4 EP Mapping & Imaging Systems
- 6.1.3.5 Insertable cardiac monitors (ICM)
- 6.1.3.6 Others
- 6.2 Global Electrophysiology Devices Market, by Indication
- 6.2.1 Market Overview
- 6.2.2 Atrial Fibrillation (AF)
- 6.2.3 Supraventricular Tachycardia (SVT)
- 6.2.4 Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
- 6.2.5 Wolff-Parkinson-White Syndrome (WPW)
- 6.2.6 Bradycardia
- 6.2.7 Others
- 6.3 Global Electrophysiology Devices Market, by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Specialty Clinics
- 6.3.4 Ambulatory Surgical Centers
- 6.3.5 Others
- 6.4 Global Electrophysiology Devices Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Electrophysiology Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Electrophysiology Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Electrophysiology Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Electrophysiology Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Electrophysiology Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Johnson & Johnson Private Limited
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 BIOTRONIK SE & Co KG
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Abbott
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Medtronic
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Boston Scientific Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 B. Braun Melsungen AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 BD
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Baxter
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Koninklijke Philips N.V.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 General Electric
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Medline Industries, Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Danaher
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Siemens Healthcare GmbH
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 MicroPort Scientific Corporation
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 LivaNova PLC
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 17.16 Cardiofocus
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisitions
- 17.16.5 Certifications
- 17.17 Mogul Enterprises, Inc.
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisitions
- 17.17.5 Certifications
- 17.18 AtriCure, Inc.
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisitions
- 17.18.5 Certifications
- 17.19 Japan Lifeline Co., Ltd.
- 17.19.1 Financial Analysis
- 17.19.2 Product Portfolio
- 17.19.3 Demographic Reach and Achievements
- 17.19.4 Mergers and Acquisitions
- 17.19.5 Certifications
- 17.20 ARGON MEDICAL
- 17.20.1 Financial Analysis
- 17.20.2 Product Portfolio
- 17.20.3 Demographic Reach and Achievements
- 17.20.4 Mergers and Acquisitions
- 17.20.5 Certifications
- 18 Global Electrophysiology Devices Market-Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Pricing Models and Strategies (Additional Insight)
- 21.1 Overview
- 21.2 Cost Model
- 21.2.1 Manufacturing Cost Analysis
- 21.2.2 Procurement Cost Analysis
- 21.2.3 Clinical Trial Cost Factors
- 21.3 Pricing Strategies
- 21.3.1 Competitor Pricing Analysis
- 21.3.2 Key Assessment of Product Attributes
- 21.3.3 Pricing Benchmark
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook